Brain Effects of Gamma Frequency Sensory Stimulation (40Hz Light, Sound and Other Devices)
Recruiting now · Phase 2
Conditions studied: Cognitively Healthy People, Alzheimer Disease
In brief
Despite the huge healthcare and economic impact of AD, there is still no disease modifying therapeutics available. In fact, the available therapeutics show low efficacy at best in the treatment of cognitive impairment in dementia. Development of a non-invasive medical device that is effective in slowing cognitive impairment is not only revolutionary but also possibly cost- effective. In this study, participants will come to MIT for a 1-day visit and the investigators will evaluate the effects of GENUS in cognitively normal, healthy adults. Investigators will use Electroencephalogram (EEG), Magnetoencephalography (MEG), magnetic resonance imaging (MRI), neuropsychological testing, and blood sampling in subsets of participants to evaluate for biological effects and safety of GENUS stimulation.
Key facts
- Study ID
- NCT07496918
- Run by
- Massachusetts Institute of Technology
- People needed
- 150
- Starts
- 2018-02-20
- Expected to finish
- 2027-01-30
- Last updated by the study team
- 2026-03-27
Who can join
Age: 18 and older, up to 100. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Have adequate visual and auditory acuity for visual and auditory stimulation to allow for neuropsychological testing.
- Be able to comply with neuropsychological testing and other study procedures in opinion of site PI.
- Exclusion Criteria: Participants will be screened for the following exclusion criteria including if they
- History of seizure or medical diagnosis of epilepsy.
- Have MRI contraindications, such as presence of pacemakers, aneurysm clips, artificial heart valves, ear implants, metal fragments, or foreign objects in the eyes, skin, or body.
- Under the discretion of the site investigator, the site investigator feels the subject cannot complete sufficient key study procedures. Exceptions to these guidelines may be considered on a case-by-case basis at the discretion of the Project Director.
Where it is running
- MIT — Cambridge, Massachusetts, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.